Earnings History Data for SELLAS Life Sciences Group, Inc. (SLS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

SELLAS Life Sciences Group, Inc.

SELLAS Life Sciences Group is a development-stage biopharmaceutical company. It focused on novel cancer immunotherapeutics for cancer indications. The company's product candidate, galinpepimut-S, is licensed from Memorial Sloan Kettering Cancer Center and targets the Wilms Tumor 1 protein, which is present in an array of tumor types. SELLAS Life Sciences Group Inc., formerly known as Galena Biopharma Inc., is based in NEW YORK, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume	Top Mover
13-05-2021	AH	4:30 PM ET (May 13)	SLS	SELLAS Life Sciences Group, Inc.	123.69	-0.16	0.00	-0.66	SELLAS Life Sciences EPS beats by $0.02 [5/13/2021 5:06 PM]	8.15	0.54 (7.10%)	8.40	0.79 (10.38%)	1.76 - 19.38	298,220	190,000	131
SELLAS Life Sciences EPS beats by $0.02 [5/13/2021 5:06 PM] SELLAS Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update [May-13-21 04:25PM]